Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

Everolimus decreased CD89 deposits in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Everolimus decreased IgA1 deposits in glomeruli of α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Everolimus decreased mesangial TfR1 expression in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Prisma flow diagram of study selection. by Hattapark Dejakaisaya (22238613)

Subjects:

No significant differences in the numbers of eggs between Mst1^+/+ and Mst1^ΔM/ΔM mice. by Jianyang Li (461703)

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

HFD decreases intermediate-term memory. by Tong Yue (6033305)

“…HFD feeding did not affect STM but significantly impaired ITM in flies (n = 12, 10, 13, 14. …”

HFD decreases ITM and alters metabolic homeostasis. by Tong Yue (6033305)

PRISMA flow diagram of study selection. by Masoud Rahmati (16665456)

Subjects:

General characteristics of included studies. by Masoud Rahmati (16665456)

Subjects:

Characteristics of individual studies. by Masoud Rahmati (16665456)

Subjects:

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

Juvenile demyelination impairs autaptic plasticity. by Sara Hijazi (21656615)

Subjects:

<b>Adipose TGR5 deletion promotes hepatic steatosis through decreasing adiponectin secretion in mice</b> by Jiahui Li (646449)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”